May 2026 Debut Biotechnology entered a strategic partnership with Natura to commercialize an AI-discovered biotechnology-derived skin longevity ingredient complex for the Latin American beauty market, strengthening innovation in active cosmetic ingredients alongside established brightening ingredients such as beta arbutin.
March 2026 Healthway expanded its production capacity for Alpha Arbutin and Beta Arbutin to more than 500 metric tons annually by upgrading its crystalline purification technology, strengthening global supply for cosmetic and dermo-cosmetic manufacturers.
June 2025 Australia's Therapeutic Goods Administration (TGA) updated the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2025, revising regulatory requirements governing the use of beta-arbutin in topical and oral medicines, providing an updated compliance framework for manufacturers and formulators.
May 2025 Kintor Pharmaceutical officially commenced the global commercial sales of its self-developed cosmetic functional raw material KT-939, expanding its portfolio of skin-brightening ingredients for cosmetic manufacturers and strengthening its presence in the functional cosmetic raw materials business.